Association between statin therapy and mortality in patients on dialysis after atherosclerotic cardiovascular diseases
Abstract Statin therapy is essential for secondary prevention in patients with atherosclerotic cardiovascular disease (ASCVD). However, the effects of statin therapy in patients receiving chronic dialysis remain uncertain. We aimed to evaluate the effect of statin therapy on long-term mortality in p...
| Main Authors: | , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Nature Portfolio
2023-07-01
|
| Series: | Scientific Reports |
| Online Access: | https://doi.org/10.1038/s41598-023-37819-1 |
| _version_ | 1797784641466269696 |
|---|---|
| author | Myunhee Lee Won Jung Choi Yunhee Lee Kyusup Lee Mahn-Won Park Jun-Pyo Myong Dae-Won Kim |
| author_facet | Myunhee Lee Won Jung Choi Yunhee Lee Kyusup Lee Mahn-Won Park Jun-Pyo Myong Dae-Won Kim |
| author_sort | Myunhee Lee |
| collection | DOAJ |
| description | Abstract Statin therapy is essential for secondary prevention in patients with atherosclerotic cardiovascular disease (ASCVD). However, the effects of statin therapy in patients receiving chronic dialysis remain uncertain. We aimed to evaluate the effect of statin therapy on long-term mortality in patients on dialysis after a first-time ASCVD. Patients receiving maintenance dialysis aged ≥ 18 years with a first-time ASCVD event between 2013 and 2018 were included in the Korean National Health Insurance Service database. Associations of statin use with long-term mortality were examined using Cox proportional hazards regression models adjusted for demographics and comorbidities. Among 17,242 patients on dialysis, 9611 (55.7%) were prescribed statins after a first-time ASCVD event. Among statin users, 7376 (76.7%) used moderate-intensity statins. During a mean follow-up of 32.6 ± 20.9 months, statin use was associated with a lower risk of all-cause mortality than statin nonuse after adjusting for confounding factors (hazard ratio [HR]: 0.92; 95% confidence interval [CI] 0.88–0.97; p = 0.0009). Despite a lack of evidence, more than half of patients on dialysis were prescribed statins after an ASCVD event. In patients on dialysis after ASCVD, statin therapy significantly reduced the risk of long-term all-cause mortality. |
| first_indexed | 2024-03-13T00:42:48Z |
| format | Article |
| id | doaj.art-a7077a8a2d4c40a8a829c7a4cb1be59a |
| institution | Directory Open Access Journal |
| issn | 2045-2322 |
| language | English |
| last_indexed | 2024-03-13T00:42:48Z |
| publishDate | 2023-07-01 |
| publisher | Nature Portfolio |
| record_format | Article |
| series | Scientific Reports |
| spelling | doaj.art-a7077a8a2d4c40a8a829c7a4cb1be59a2023-07-09T11:14:06ZengNature PortfolioScientific Reports2045-23222023-07-0113111010.1038/s41598-023-37819-1Association between statin therapy and mortality in patients on dialysis after atherosclerotic cardiovascular diseasesMyunhee Lee0Won Jung Choi1Yunhee Lee2Kyusup Lee3Mahn-Won Park4Jun-Pyo Myong5Dae-Won Kim6Division of Cardiology, Department of Internal Medicine, Daejeon St. Mary’s Hospital, The Catholic University of KoreaDivision of Nephrology, Department of Internal Medicine, Daejeon St. Mary’s Hospital, The Catholic University of KoreaDepartment of Urology, Seoul St. Mary’s Hospital, The Catholic University of KoreaDivision of Cardiology, Department of Internal Medicine, Daejeon St. Mary’s Hospital, The Catholic University of KoreaDivision of Cardiology, Department of Internal Medicine, Daejeon St. Mary’s Hospital, The Catholic University of KoreaDepartment of Occupational and Environmental Medicine, Seoul St. Mary’s Hospital, The Catholic University of KoreaDivision of Cardiology, Department of Internal Medicine, Daejeon St. Mary’s Hospital, The Catholic University of KoreaAbstract Statin therapy is essential for secondary prevention in patients with atherosclerotic cardiovascular disease (ASCVD). However, the effects of statin therapy in patients receiving chronic dialysis remain uncertain. We aimed to evaluate the effect of statin therapy on long-term mortality in patients on dialysis after a first-time ASCVD. Patients receiving maintenance dialysis aged ≥ 18 years with a first-time ASCVD event between 2013 and 2018 were included in the Korean National Health Insurance Service database. Associations of statin use with long-term mortality were examined using Cox proportional hazards regression models adjusted for demographics and comorbidities. Among 17,242 patients on dialysis, 9611 (55.7%) were prescribed statins after a first-time ASCVD event. Among statin users, 7376 (76.7%) used moderate-intensity statins. During a mean follow-up of 32.6 ± 20.9 months, statin use was associated with a lower risk of all-cause mortality than statin nonuse after adjusting for confounding factors (hazard ratio [HR]: 0.92; 95% confidence interval [CI] 0.88–0.97; p = 0.0009). Despite a lack of evidence, more than half of patients on dialysis were prescribed statins after an ASCVD event. In patients on dialysis after ASCVD, statin therapy significantly reduced the risk of long-term all-cause mortality.https://doi.org/10.1038/s41598-023-37819-1 |
| spellingShingle | Myunhee Lee Won Jung Choi Yunhee Lee Kyusup Lee Mahn-Won Park Jun-Pyo Myong Dae-Won Kim Association between statin therapy and mortality in patients on dialysis after atherosclerotic cardiovascular diseases Scientific Reports |
| title | Association between statin therapy and mortality in patients on dialysis after atherosclerotic cardiovascular diseases |
| title_full | Association between statin therapy and mortality in patients on dialysis after atherosclerotic cardiovascular diseases |
| title_fullStr | Association between statin therapy and mortality in patients on dialysis after atherosclerotic cardiovascular diseases |
| title_full_unstemmed | Association between statin therapy and mortality in patients on dialysis after atherosclerotic cardiovascular diseases |
| title_short | Association between statin therapy and mortality in patients on dialysis after atherosclerotic cardiovascular diseases |
| title_sort | association between statin therapy and mortality in patients on dialysis after atherosclerotic cardiovascular diseases |
| url | https://doi.org/10.1038/s41598-023-37819-1 |
| work_keys_str_mv | AT myunheelee associationbetweenstatintherapyandmortalityinpatientsondialysisafteratheroscleroticcardiovasculardiseases AT wonjungchoi associationbetweenstatintherapyandmortalityinpatientsondialysisafteratheroscleroticcardiovasculardiseases AT yunheelee associationbetweenstatintherapyandmortalityinpatientsondialysisafteratheroscleroticcardiovasculardiseases AT kyusuplee associationbetweenstatintherapyandmortalityinpatientsondialysisafteratheroscleroticcardiovasculardiseases AT mahnwonpark associationbetweenstatintherapyandmortalityinpatientsondialysisafteratheroscleroticcardiovasculardiseases AT junpyomyong associationbetweenstatintherapyandmortalityinpatientsondialysisafteratheroscleroticcardiovasculardiseases AT daewonkim associationbetweenstatintherapyandmortalityinpatientsondialysisafteratheroscleroticcardiovasculardiseases |